Table 4.
Effect of SL-A002 extract against L1210 lymphoid leukemia in CDF1 mice.
| Treatments | Dose (mg/kg) | Mean survival time | Increase in mean survival time (%) | Inference | 
|---|---|---|---|---|
| Normal saline | (0.2 mL/mouse) | 12 | — | — | 
| 5-FU | 20 | 19 | 158.33 | Significant activity | 
| SL-A002 | 100 | 19 | 158.33 | Significant activity | 
T/C% < 125% = toxic/inactive.
T/C% > 125% = significant antileukemic effect.
n = 6,10 for control.